Vendor, Rockville, MD, part of Merck Kommanditgesellschaft Auf Aktien
Bioreliance Corporation
UEI H3KAG9A26K77, CAGE 1CPE3
9 awards and $438,658 obligated between March 14, 2024 and August 20, 2026, 0% under full and open competition, against 1.1 offers on average where reported. 2 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Centers for Disease Control and Prevention | $376,305 |
| National Institutes of Health | $62,353 |
Industries
NAICS on the awards, by dollars.
| Medical LaboratoriesNAICS 621511 | $248,779 |
| Testing Laboratories and ServicesNAICS 541380 | $117,181 |
| Refrigerated Warehousing and StorageNAICS 493120 | $41,284 |
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $31,414 |
| All Other Professional, Scientific, and Technical ServicesNAICS 541990 | $0 |
How it wins
Awards by competition, set-aside and type.
| Not Competed Under SAP | 7 |
| Competed Under SAP | 1 |
| Not Competed | 1 |
| Purchase Order | 8 |
| Definitive Contract | 1 |
Hear when Bioreliance Corporation wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of Bioreliance Corporation's contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling medical laboratories to Centers for Disease Control and Prevention, by dollars.
| Navitas Clinical Research Inc.Gaithersburg, MD | $5,224,102 |
| Aegis Sciences CorporationNashville, TN | $985,821 |
| Srisai Biopharmaceutical Solutions LLCFrederick, MD | $406,044 |
| Laboratory Corporation of America HoldingsBurlington, NC | $19,050 |
| Quest Diagnostics Nichols InstituteSan Juan Capistrano, CA | $0 |
| RPRD Diagnostics, LLCMilwaukee, WI | $0 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Follow-up testing for tumorigenicity and oncogenicity
Centers for Disease Control and Prevention, CDC Office of Acquisition Services
Combined synopsis and solicitationNAICS 621511Atlanta, GA75D301-24-Q-78224Awarded to Bioreliance Corporation
Posted Aug 21, 20242 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75D30124P19870Purchase Order, September 26, 2024, Competed Under SAP, 2 offersSolicitation | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Follow-Up Testing for Tumorigenicity and Oncogenicity.NAICS 621511, PSC Q301 | $248,779 |
| 75D30121P10233Purchase Order, April 1, 2024, Not Competed Under SAP, 1 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Storage Renewal for CDC Vero and MDCK CellsNAICS 541380, PSC Q301 | $54,828 |
| 75D30126P21070Purchase Order, May 29, 2026, Not Competed Under SAP, 1 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Cryogenic Storage of CGMP Grade Cell Banks-Eo 14398NAICS 493120, PSC AJ13 | $41,284 |
| 75D30121C10819Definitive Contract, April 17, 2024, Not Competed, 1 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Bioreliance Expi293fNAICS 541714, PSC AN12 | $31,414 |
| 75N93025P00260Purchase Order, January 17, 2025, Not Competed Under SAP, 1 offers | National Institutes of Health NiaidNational Institutes of Health | Bioreliance Corp Endotoxin and Sterility Testing ServicesNAICS 541380, PSC Q301 | $16,051 |
| 75N93024P00543Purchase Order, April 17, 2024, Not Competed Under SAP, 1 offers | National Institutes of Health NiaidNational Institutes of Health | Endotoxin and Sterility Testing ServicesNAICS 541380, PSC Q301 | $15,434 |
| 75N93024P00571Purchase Order, April 22, 2024, Not Competed Under SAP, 1 offers | National Institutes of Health NiaidNational Institutes of Health | Bioreliance Endotoxin and Sterility TestingNAICS 541380, PSC B504 | $15,434 |
| 75N93024P01101Purchase Order, September 5, 2024, Not Competed Under SAP, 1 offers | National Institutes of Health NiaidNational Institutes of Health | Bioreliance Corp Endotoxin and Sterility Testing ServicesNAICS 541380, PSC Q301 | $15,434 |
| HHSD2002016M90017PPurchase Order, March 14, 2024, Not Competed Under SAP, 1 offers | CDC Office of Acquisition ServicesCenters for Disease Control and Prevention | Exercise Option 2NAICS 541990, PSC L039 | $0 |
- Product and service codes
- Q301 Reference Laboratory TestingAJ13 General Science & Technology R&D Svcs; General Science & Technology; Experimental DevelopmentAN12 Health R&D Services; Health Care Services; Applied ResearchB504 Chemical/Biological Studies and AnalysisL039 Technical Representation Services: Materials Handling Equipment
- Transactions
- 16 across 9 awards